Reaction Details Report a problem with these data
Target
Tumor protein p53-inducible nuclear protein 2
Ligand
BDBM449170
Substrate
n/a
Meas. Tech.
Radioligand Binding Assay
EC50
440±n/a nM
Citation
 Shoichet, BK; Lin, H; Gmeiner, P; Manglik, A; Kobilka, B; Roth, BL; Dengler, DG MU opioid receptor modulators US Patent  US10702498 Publication Date 7/7/2020 
Target
Name:
Tumor protein p53-inducible nuclear protein 2
Synonyms:
C20orf110 | DOR | Diabetes and obesity-regulated gene | PIG-U | PINH | T53I2_HUMAN | TP53INP2 | p53-inducible protein U
Type:
Protein
Mol. Mass.:
23980.20
Organism:
Human
Description:
Q8IXH6
Residue:
220
Sequence:
MFQRLSSLFFSTPSPPEDPDCPRAFVSEEDEVDGWLIIDLPDSYAAPPSPGAAPAPAGRPPPAPSLMDESWFVTPPACFTAEGPGLGPARLQSSPLEDLLIEHPSMSVYVTGSTIVLEPGSPSPLPDAALPDGDLSEGELTPARREPRAARHAAPLPARAALLEKAGQVRRLQRARQRAERHALSAKAVQRQNRARESRPRRSKNQSSFIYQPCQRQFNY
  
Inhibitor
Name:
BDBM449170
Synonyms:
US10702498, Compound 14 | US11484525, Compound 14
Type:
Small organic molecule
Emp. Form.:
C19H25N4O3
Mol. Mass.:
357.4263
SMILES:
C[NH+](C)[C@H](CNC(=O)NCc1cccc(c1)[N+]([O-])=O)Cc1ccccc1 |r|
Structure:
Search PDB for entries with ligand similarity: